|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Actelion Ltd., of Allschwil, Switzerland, said its bearer shares would be listed on the SWX Main Market as of Sept. 9. Actelion initially listed on the SWX New Market in April 2000. Actelion's drug, Tracleer, is an orally available dual endothelin receptor antagonist and has been approved to treat pulmonary arterial hypertension.
Applied Biosystems Group, of Foster City, Calif., and the Institute for Systems Biology in Seattle are collaborating to develop technologies and applications in proteomics. The institute plans to use Applied Biosystems' 4700 Proteomics Analyzer with TOF/TOF Optics and the ICAT reagent technology in its efforts to study the dynamics of ...